CNBC
US · 2 hrs ago
✦ 72◉ Centre
Why J&J thinks its new psoriasis pill could be one of its biggest drugs ever
72Quality
0Ratings
0Comments
AI Analysis
Quality 72/100
Partisan intensity 35/100
ObjectivePartisan
◉ Centre ✓ Fair headline
Johnson & Johnson is positioning its new psoriasis medication Icotyde as a potential major revenue driver, with investors viewing it as key to accelerating the company's growth trajectory.
Why J&J thinks its new psoriasis pill could be one of its biggest drugs ever
Investors are counting drugs like Icotyde to accelerate J&J's revenue growth rate.
Discussion 0 comments
Sort:
?
No comments yet — be the first to start the discussion!